001     1049996
005     20251219202234.0
024 7 _ |a 10.1111/ene.70453
|2 doi
024 7 _ |a 1351-5101
|2 ISSN
024 7 _ |a 1468-1331
|2 ISSN
024 7 _ |a 10.34734/FZJ-2025-05710
|2 datacite_doi
037 _ _ |a FZJ-2025-05710
082 _ _ |a 610
100 1 _ |a Vieregge, Magdalena
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a Dermal Alpha‐Synuclein Aggregation in Seed Amplification Assays for Parkinson's Disease Subtype Differentiation
260 _ _ |a Oxford [u.a.]
|c 2025
|b Wiley-Blackwell
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1766153274_23461
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a This work was supported by German Federal Ministry of Education and Research (BMBF). We thank Andrea Sauer-Weckertand Antonia Kohl for expert technicalassistance. Kathrin Doppler is supported by grants from theInterdisciplinary Center of Clinical Research of the University HospitalWürzburg and by the German Research Foundation as a member of theClinical Research Unit ResolvePain. Brain lysates were kindly providedby Camelia Monoranu. Michael Sommerauer receives funding from theprogram “Netzwerke 2021”, an initiative of the Ministry of Culture andScience of the State of Northrhine-Westphalia,and from the FederalMinistry of Education and Research (BMBF) within the frameworkof the funding programme ACCENT (funding code 01EO2107). OpenAccess funding enabled and organized by Projekt DEAL.
520 _ _ |a Skin biopsies and seed amplification assays (SAA) provide a sensitive and potentially quantitative method to detect alpha‐synuclein (a‐syn) aggregation in peripheral nerve fibers in Parkinson's disease (PD). Relating to the previously published hypothesis that PD may either originate in the peripheral (body‐first) or central (brain‐first) nervous system, we investigated whether patients with clinical features that have been reported to be associated with a suspected body‐first subtype of PD exhibit higher levels of a‐syn aggregation in dermal nerve fibers compared to those without these features. Patients with isolated REM sleep behavior disorder (iRBD) representing a suspected premotor stage of body‐first PD were studied in comparison to the PD cohort.MethodsPatients were categorized on the basis of clinical features, and SAA parameters such as lag time, number of positive curves, and titers were analyzed and correlated with clinical features.ResultsAlthough patients with clinical features of suspected body‐first PD showed slightly higher titers, significant differences were mainly observed between iRBD patients and PD patients.
536 _ _ |a 5252 - Brain Dysfunction and Plasticity (POF4-525)
|0 G:(DE-HGF)POF4-5252
|c POF4-525
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Kuzkina, Anastasia
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Janzen, Annette
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Oertel, Wolfgang H.
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Sommerauer, Michael
|0 P:(DE-Juel1)179044
|b 4
700 1 _ |a Volkmann, Jens
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Doppler, Kathrin
|0 0000-0003-2883-0009
|b 6
|e Corresponding author
773 _ _ |a 10.1111/ene.70453
|g Vol. 32, no. 12, p. e70453
|0 PERI:(DE-600)2020241-6
|n 12
|p e70453
|t European journal of neurology
|v 32
|y 2025
|x 1351-5101
856 4 _ |u https://juser.fz-juelich.de/record/1049996/files/PDF.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:1049996
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)179044
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5252
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-12
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J NEUROL : 2022
|d 2024-12-12
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2024-12-12
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-12
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-12
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b EUR J NEUROL : 2022
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-12
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21